Which has preferable earnings & valuation, GH or PACS?

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 16.95 -$416.28M -$3.39 N/A PACS Group $5.29B 1.05 $191.54M $1.56 22.53

Does the media refer more to GH or PACS?

In the previous week, Guardant Health had 16 more articles in the media than PACS Group. MarketBeat recorded 17 mentions for Guardant Health and 1 mentions for PACS Group. Guardant Health's average media sentiment score of 0.45 beat PACS Group's score of -0.35 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 6 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral PACS Group 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to BTSG or PACS?

In the previous week, BrightSpring Health Services had 17 more articles in the media than PACS Group. MarketBeat recorded 18 mentions for BrightSpring Health Services and 1 mentions for PACS Group. BrightSpring Health Services' average media sentiment score of 0.73 beat PACS Group's score of -0.35 indicating that BrightSpring Health Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 7 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer PACS or FMS?

In the previous week, Fresenius Medical Care AG & Co. KGaA had 1 more articles in the media than PACS Group. MarketBeat recorded 2 mentions for Fresenius Medical Care AG & Co. KGaA and 1 mentions for PACS Group. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.71 beat PACS Group's score of -0.35 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Fresenius Medical Care AG & Co. KGaA 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, PACS or CELC?

PACS Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.29B 1.05 $191.54M $1.56 22.53 Celcuity N/A N/A -$177.04M -$3.90 N/A

Is PACS or CELC more profitable?

PACS Group has a net margin of 4.49% compared to Celcuity's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets PACS Group 4.49% 26.47% 4.36% Celcuity N/A -244.61% -50.22%

Does the media prefer PACS or CELC?

In the previous week, Celcuity had 32 more articles in the media than PACS Group. MarketBeat recorded 33 mentions for Celcuity and 1 mentions for PACS Group. Celcuity's average media sentiment score of -0.09 beat PACS Group's score of -0.35 indicating that Celcuity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Celcuity 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 7 Very Negative mention(s) Neutral

Which has better valuation and earnings, PACS or HIMS?

PACS Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.29B 1.05 $191.54M $1.56 22.53 Hims & Hers Health $2.35B 2.71 $128.37M -$0.09 N/A

Does the media favor PACS or HIMS?

In the previous week, Hims & Hers Health had 15 more articles in the media than PACS Group. MarketBeat recorded 16 mentions for Hims & Hers Health and 1 mentions for PACS Group. Hims & Hers Health's average media sentiment score of 0.92 beat PACS Group's score of -0.35 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Hims & Hers Health 10 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

PACS Group (PACS) Competitors

$35.14 +0.07 (+0.20%)

As of 01:33 PM Eastern

Compare

PACS vs. GH, BTSG, FMS, CELC, and HIMS

Should you buy PACS Group stock or one of its competitors? MarketBeat compares PACS Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with PACS Group include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Celcuity (CELC), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry.

How does PACS Group compare to Guardant Health?

Guardant Health (NASDAQ:GH) and PACS Group (NYSE:PACS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

Guardant Health presently has a consensus target price of $139.80, suggesting a potential upside of 11.37%. PACS Group has a consensus target price of $48.00, suggesting a potential upside of 36.60%. Given PACS Group's higher possible upside, analysts clearly believe PACS Group is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	2.95
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

PACS Group has a net margin of 4.49% compared to Guardant Health's net margin of -40.10%. PACS Group's return on equity of 26.47% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
PACS Group	4.49%	26.47%	4.36%

In the previous week, Guardant Health had 16 more articles in the media than PACS Group. MarketBeat recorded 17 mentions for Guardant Health and 1 mentions for PACS Group. Guardant Health's average media sentiment score of 0.45 beat PACS Group's score of -0.35 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	6 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
PACS Group	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	16.95	-$416.28M	-$3.39	N/A
PACS Group	$5.29B	1.05	$191.54M	$1.56	22.53

92.6% of Guardant Health shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Comparatively, 70.1% of PACS Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

PACS Group beats Guardant Health on 9 of the 16 factors compared between the two stocks.

How does PACS Group compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and PACS Group (NYSE:PACS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

BrightSpring Health Services presently has a consensus price target of $58.53, suggesting a potential downside of 3.16%. PACS Group has a consensus price target of $48.00, suggesting a potential upside of 36.60%. Given PACS Group's higher probable upside, analysts plainly believe PACS Group is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	3.11
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

PACS Group has a net margin of 4.49% compared to BrightSpring Health Services' net margin of 2.27%. PACS Group's return on equity of 26.47% beat BrightSpring Health Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
PACS Group	4.49%	26.47%	4.36%

In the previous week, BrightSpring Health Services had 17 more articles in the media than PACS Group. MarketBeat recorded 18 mentions for BrightSpring Health Services and 1 mentions for PACS Group. BrightSpring Health Services' average media sentiment score of 0.73 beat PACS Group's score of -0.35 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	7 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group has lower revenue, but higher earnings than BrightSpring Health Services. PACS Group is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$13.65B	0.87	$190.67M	$1.41	42.87
PACS Group	$5.29B	1.05	$191.54M	$1.56	22.53

Summary

BrightSpring Health Services beats PACS Group on 8 of the 14 factors compared between the two stocks.

How does PACS Group compare to Fresenius Medical Care AG & Co. KGaA?

PACS Group (NYSE:PACS) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

PACS Group presently has a consensus target price of $48.00, indicating a potential upside of 36.60%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, indicating a potential upside of 25.59%. Given PACS Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe PACS Group is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 70.1% of PACS Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Fresenius Medical Care AG & Co. KGaA had 1 more articles in the media than PACS Group. MarketBeat recorded 2 mentions for Fresenius Medical Care AG & Co. KGaA and 1 mentions for PACS Group. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.71 beat PACS Group's score of -0.35 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to PACS Group's net margin of 4.49%. PACS Group's return on equity of 26.47% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than PACS Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.05	$191.54M	$1.56	22.53
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.90	11.73

Summary

PACS Group beats Fresenius Medical Care AG & Co. KGaA on 8 of the 15 factors compared between the two stocks.

How does PACS Group compare to Celcuity?

PACS Group (NYSE:PACS) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership.

63.3% of Celcuity shares are owned by institutional investors. 70.1% of PACS Group shares are owned by insiders. Comparatively, 13.3% of Celcuity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Celcuity had 32 more articles in the media than PACS Group. MarketBeat recorded 33 mentions for Celcuity and 1 mentions for PACS Group. Celcuity's average media sentiment score of -0.09 beat PACS Group's score of -0.35 indicating that Celcuity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Celcuity	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	7 Very Negative mention(s)	Neutral

PACS Group presently has a consensus target price of $48.00, indicating a potential upside of 36.60%. Celcuity has a consensus target price of $152.09, indicating a potential upside of 65.08%. Given Celcuity's stronger consensus rating and higher possible upside, analysts plainly believe Celcuity is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

PACS Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.05	$191.54M	$1.56	22.53
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

PACS Group has a net margin of 4.49% compared to Celcuity's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Celcuity	N/A	-244.61%	-50.22%

Summary

PACS Group beats Celcuity on 8 of the 14 factors compared between the two stocks.

How does PACS Group compare to Hims & Hers Health?

PACS Group (NYSE:PACS) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

PACS Group presently has a consensus target price of $48.00, suggesting a potential upside of 36.60%. Hims & Hers Health has a consensus target price of $28.70, suggesting a potential upside of 4.44%. Given PACS Group's stronger consensus rating and higher possible upside, research analysts plainly believe PACS Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

63.5% of Hims & Hers Health shares are held by institutional investors. 70.1% of PACS Group shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Hims & Hers Health had 15 more articles in the media than PACS Group. MarketBeat recorded 16 mentions for Hims & Hers Health and 1 mentions for PACS Group. Hims & Hers Health's average media sentiment score of 0.92 beat PACS Group's score of -0.35 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hims & Hers Health	10 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PACS Group has a net margin of 4.49% compared to Hims & Hers Health's net margin of -0.56%. PACS Group's return on equity of 26.47% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Hims & Hers Health	-0.56%	6.10%	1.52%

PACS Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.05	$191.54M	$1.56	22.53
Hims & Hers Health	$2.35B	2.71	$128.37M	-$0.09	N/A

Summary

PACS Group beats Hims & Hers Health on 11 of the 15 factors compared between the two stocks.

Get PACS Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PACS vs. The Competition

Export

Metric	PACS Group	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$5.57B	$8.79B	$6.44B	$22.78B
Dividend Yield	N/A	1.76%	2.67%	4.10%
P/E Ratio	22.57	22.99	23.83	29.83
Price / Sales	1.05	25.83	529.24	12.65
Price / Cash	23.15	12.81	26.99	18.46
Price / Book	5.78	5.33	10.46	4.59
Net Income	$191.54M	$177.20M	$3.56B	$1.07B
7 Day Performance	-4.57%	-1.34%	-1.94%	-2.30%
1 Month Performance	4.63%	4.97%	0.29%	-1.60%
1 Year Performance	237.72%	2.52%	19.72%	19.23%

PACS Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PACS PACS Group	4.2912 of 5 stars	$35.14 +0.2%	$48.00 +36.6%	+237.2%	$5.57B	$5.29B	22.57	47,455	Analyst Downgrade
GH Guardant Health	2.4226 of 5 stars	$128.27 -1.1%	$136.37 +6.3%	+159.9%	$17.20B	$1.08B	N/A	2,506	Analyst Forecast Insider Trade
BTSG BrightSpring Health Services	4.0116 of 5 stars	$58.29 -5.5%	$57.64 -1.1%	+145.6%	$11.96B	$12.91B	42.56	23,500	Positive News Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.8521 of 5 stars	$20.73 -3.9%	$28.00 +35.1%	-23.6%	$11.65B	$19.36B	11.03	1,488
CELC Celcuity	3.0639 of 5 stars	$93.41 -29.7%	$150.27 +60.9%	+570.0%	$6.48B	N/A	N/A	40

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PACS) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PACS Group (PACS) Competitors

PACS vs. GH, BTSG, FMS, CELC, and HIMS

How does PACS Group compare to Guardant Health?

Summary

How does PACS Group compare to BrightSpring Health Services?

Summary

How does PACS Group compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does PACS Group compare to Celcuity?

Summary

How does PACS Group compare to Hims & Hers Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PACS vs. The Competition

PACS Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PACS Group (PACS) Competitors

PACS vs. GH, BTSG, FMS, CELC, and HIMS

How does PACS Group compare to Guardant Health?

Do analysts recommend GH or PACS?

Is GH or PACS more profitable?

Does the media refer more to GH or PACS?

Which has preferable earnings & valuation, GH or PACS?

Do insiders and institutionals believe in GH or PACS?

Summary

How does PACS Group compare to BrightSpring Health Services?

Do analysts recommend BTSG or PACS?

Is BTSG or PACS more profitable?

Does the media refer more to BTSG or PACS?

Which has preferable valuation & earnings, BTSG or PACS?

Summary

How does PACS Group compare to Fresenius Medical Care AG & Co. KGaA?

Do analysts recommend PACS or FMS?

Do institutionals and insiders believe in PACS or FMS?

Does the media prefer PACS or FMS?

Is PACS or FMS more profitable?

Which has preferable earnings & valuation, PACS or FMS?

Summary

How does PACS Group compare to Celcuity?

Do institutionals & insiders have more ownership in PACS or CELC?

Does the media prefer PACS or CELC?

Do analysts rate PACS or CELC?

Which has stronger earnings and valuation, PACS or CELC?

Is PACS or CELC more profitable?

Summary

How does PACS Group compare to Hims & Hers Health?

Do analysts prefer PACS or HIMS?

Do insiders and institutionals hold more shares of PACS or HIMS?

Does the media favor PACS or HIMS?

Is PACS or HIMS more profitable?

Which has better valuation and earnings, PACS or HIMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PACS vs. The Competition

PACS Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools